{
  "id": 9306852,
  "title": "Citizens reiterates Union Pacific stock rating on valuation outlook",
  "url": "https://urgent.news/2026/09/23/citizens-reiterates-union-pacific-stock-rating-on-valuation-outlook",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-23T09:38:48.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/citizens-reiterates-union-pacific-stock-rating-on-valuation-outlook-93CH-4912411"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Citizens reiterates Rapport Therapeutics stock rating on Phase 2 trial potential",
        "url": "https://urgent.news/2026/09/23/citizens-reiterates-rapport-therapeutics-stock-rating-on-phase-2",
        "published": "2026-09-23T09:38:47.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}